è¡ç³èª¿æŽã·ã¹ãã ãŸãšã.
è¡ç³å€ãšã¯
è¡æ¶²å ã®ðã°ã«ã³ãŒã¹ã®æ¿åºŠ.
æ£åžžãªè¡ç³å€ã®ç¯å²
- ç©ºè ¹æ: 70-100 mg/dLïŒå¥åžžè ïŒ
- é£åŸ2æé: 140 mg/dLæªæºïŒå¥åžžè ïŒ
- äœè¡ç³: 70 mg/dLæªæº
- é«è¡ç³: 180 mg/dL以äžïŒç³å°¿ç 管çç®æšïŒ
è¡ç³å€ãå€åããèŠå
äžæ
- é£äº: çæ°Žåç©æåã§äžæ
- ã«ãã§ã€ã³ã®è¡ç³äžæäœçš
äœäž
- éå: éåžžã¯äœäžïŒæ¿ããéåã¯äžæçã«äžæããããšãïŒ
- ã¹ãã¬ã¹: ã³ã«ããŸãŒã«ãªã©ã§äžæ
- ç¡ç : å€éãæ©æã«ç¹æã®ãã¿ãŒã³
- ãã«ã¢ã³: æé·ãã«ã¢ã³ãã€ã³ã¹ãªã³ãªã©
æé垯å¥ã®ç¹åŸŽ
å€éïŒå°±å¯äžïŒ
- æãå®å®ãã¹ãæé垯
- å€éäœè¡ç³ã«æ³šæïŒç¡èªèŠã®å¯èœæ§ïŒ
æ©æïŒ4-8æïŒ
- æçŸè±¡ã§äžæãããã
- ç©ºè ¹æè¡ç³å€ã®ç¢ºèªã«éèŠ60
é£åŸïŒ1-3æéïŒ
- ããŒã¯å€ãšãã®å°éæé
- æ£åžžãªã140-160 mg/dLçšåºŠã§åãŸã
ãœã¢ãžãŒå¹æ
äž»ã«ã€ã³ã¹ãªã³æ²»çäžã®ç³å°¿ç æ£è ã«ãããŠãå€éäœè¡ç³ã®ååã§æ©æã«é«è¡ç³ãšãªãçŸè±¡.
æçŸè±¡
4-8æå°ã®è¡ç³å€äžæ.
ðæé·ãã«ã¢ã³å¹æ.
ã»ã«ã³ãããŒã«å¹æ
1æ¥ã®æåã®é£äºïŒãã¡ãŒã¹ãããŒã«ïŒã®å 容ããæ¬¡ã«æãé£äºïŒã»ã«ã³ãããŒã«ïŒã®åŸã®è¡ç³å€äžæãæããçŸè±¡ã§ããæé£ã«é£ç©ç¹ç¶ãã¿ã³ãã¯è³ªãå€ãæãããšã§ãæŒé£ã®è¡ç³å€ãå®å®
ðã€ã³ã¹ãªã³æµææ§
ã€ã³ã¹ãªã³æåæ§. ã€ã³ã¹ãªã³ã®å¹ãç®ãæªãç¶æ .
ðGLUT4
ã°ã«ã³ãŒã¹ãã©ã³ã¹ããŒã¿ãŒ. ããã£ãšãã©ãŒ.
éªšæ Œçãèèªçްèã«ååšããã€ã³ã¹ãªã³äŸåæ§ã®ã°ã«ã³ãŒã¹èŒžéäœïŒã¿ã³ãã¯è³ªïŒ
ã€ã³ã¹ãªã³ã®åºæ¿ã«ãã现èå ã®å°èãã现èèãžç§»åããè¡æ¶²äžã®ç³ã现èå ã«åã蟌ãããšã§è¡ç³å€ãäžãã圹å²ãæ ããŸã
é£äºãšè¡ç³å€
è¡ç³å€äžæäž(é£åŸ15ã60å)
- éåã¯æã广ç
- è¡ç³å€ã®äžæã«ãŒããç·©ããã«ããããŒã¯èªäœãäœãæãã
- ã¹ãã€ã¯ã®ãé«ãããåã
è¡ç³å€ããŒã¯
- ã ããã60å-90åã§ããŒã¯.
- éåžžã140 mg/dLæªæº
äžéæ
- ããŒã¯ãã2ã3æéãããŠäžé
- é£åŸ3ã4æéã§ç©ºè ¹æã¬ãã«ã«æ»ã
- ç©ºè ¹æè¡ç³å€ïŒ70ã100 mg/dLçšåºŠïŒ
ðè¡ç³å€ã¹ãã€ã¯
è¡ç³å€ãæ¥äžæããŠæ¥éäž. ããŒã¯ã®è¡ç³å€ãé«ããªãã®ã§ããã®ååãšããŠã®ã€ã³ã¹ãªã³ãå¢ãã.
ð€ç æ°ãåŠæ æã®åå .
ðåå¿æ§äœè¡ç³
é£åŸã«äžæçã«è¡ç³å€ãæ¥äžæããåŸããããäžããããšããŠã€ã³ã¹ãªã³ãéå°ã«åæ³ãããããšã§ãå¿ èŠä»¥äžã«è¡ç³ãäœäžããŠããŸãç¶æ (æ£åžžãªã²ãšã¯ç©ºè ¹æã§æ¢ãŸã). ç©ºè ¹æã¬ãã«ããäœããªã.
çç¶
é£åŸ2ã4æéåŸã«
- ç ããªã. ç ãã§ã¯ãªãåŠæ æã«æ¢åã®ç¡ç å§ã衚é¢åãã.
- ã€ã©ã€ã©ãã. è¡ç³å€ãäžãããšã¡ã³ã¿ã«ãäžå®å®ã«ãªã.
ã¡ã«ããºã
- è¡ç³å€æ¥éäžã®æ€ç¥. è¡ç³å€ãæ¥æ¿ã«äžãããšãè³ïŒç¹ã«èŠåºäžéšïŒããšãã«ã®ãŒå±æ©ãæ€ç¥
- 察æãã«ã¢ã³ã®åæ³: ã³ã«ããŸãŒã«ãã¢ãã¬ããªã³ãã°ã«ã«ãŽã³ãåæ³ããã
- ãããã¯è¡ç³å€ãäžããããã®ãã«ã¢ã³ã ããåæã«äº€æç¥çµã掻æ§åããã
- è³ãžã®åœ±é¿: è³ã¯äž»ã«ã°ã«ã³ãŒã¹ããšãã«ã®ãŒæºãšãããããäœè¡ç³ã§æ©èœäœäž
- åé åç®è³ªïŒçæ§ã»ææ å¶åŸ¡ïŒã®ããã©ãŒãã³ã¹ãèœã¡ã
- ææ¡äœïŒæ ååå¿ïŒã®æå¶ãå¹ããªããªã
察æãã«ã¢ã³
åå¿æ§äœè¡ç³ããã®ãªããŠã³ã.
äžãã£ããšããäœããè¡ç³ãäžãããããããšå€æããã°ã«ã«ãŽã³ã»ã¢ãã¬ããªã³ãåæ³ãããŠèèããã°ã«ã³ãŒã¹ãå€§éæŸåºãããããã®ãéè£æ£ãã§æ¥äžæ.
è¡ç³ãæ¥èœãããã³ã«å¯Ÿæãã«ã¢ã³ãéå°åå¿. é£äºãªãã§ãæ¥äžæ.
<2026-02-18 Wed 15:07>å匷ã«ãã§ã§åº§ã£ãŠãã ããªã®ã«ã°ã³ã°ã³ããã£ãâŠ
é£åŸã®ã«ãã§ã€ã³æå
ç³å°¿ç ã§ãªã人ã§ãé£åŸã®ã«ãã§ã€ã³æåã§è¡ç³ãå¹³å+10ã25%äžæãããšããå ±åãè€æ°ãã.ãã ãå人差ã倧ãã.
- èèããã®ã°ã«ã³ãŒã¹æŸåº
- ã€ã³ã¹ãªã³æåæ§ã®äœäž
<2026-02-18 Wed 15:06>ãããã¯ãã®ãã¿ãŒã³ãããããå°ãå®éš. é£åŸã ããšããå¯èœæ§ããã. ãã¿ãŒã³ãŒããŒã¯ã©ãã ãããïŒ
ç¡ç ãšè¡ç³å€
- å€ã¯ç³è³ªãåããªãã®ãçæ³.
- çæ³ã¯ç¡ç é4æéå.
ç¡ç äžã®è¡ç³å€ãšHRVïŒå¿æå€åïŒã«äžçšåºŠã®è² ã®çžé¢
è¡ç³å€ãäžæãããšïŒ
- HRVãäœäžïŒèªåŸç¥çµã®æè»æ§ã倱ãããïŒ
- å¯äº€æç¥çµæ©èœãäœäž
- å¿ææ°ãçžå¯Ÿçã«äœãåºå®ãããåŸå
ðGIå€
é£åãè¡ç³å€ãäžæãããéåºŠãæ°å€åãããã®. ã°ãªã»ããã¯ã»ã€ã³ããã¯ã¹
é«GI
- é£ãã³ããã¡ã粟çœç±³ããã©ãã
- ããããããããŸããããã³ãžã³
- ãã§ã³ã¬ãŒããããŒãã
äœGIé£å
- çæ°Žåç©: ã¹ãã²ããã£ãæ¥æ¬ãã°ãã©ã€éºŠãã³ãçç±³ããªãŒã«ãã©ã³ãæ¥éš
- ãã€ãŸãã
- çããããããããã£ãããªã©ã®éè
- ãã®ãã ãããšãªã³ã®ãã·ã¡ãžãæåžãªã©ã®ããã³é¡ãæµ·è»é¡
äºæž¬åŒ
æ©æ¢°åŠç¿.
GL = 19.27 + (0.39 à å©çšå¯èœçæ°Žåç©) - (0.21 à è質)
- (0.01 à ã¿ã³ãã¯è³ªÂ²) - (0.01 à é£ç©ç¹ç¶Â²)
ref. https://www.mdpi.com/2304-8158/10/11/2626, Development of a Prediction Model to Estimate the Glycemic Load of Ready-to-Eat Meals (2021)
GI倿代é ã説
- 極ããŠé«ãå€åæ§
- GIå€ã¯åäžäººç©ã§ã20%ãå人éã§ã¯25%ãå€åãã
- ç ç©¶ãã¶ã€ã³ã®éå€§ãªæ¬ é¥
- 調çã»å å·¥ã§å€§ããå€åïŒ
- éãèæ ®ããŠããªã
èšæž¬åš
æå ç©¿åº(SMBG)
è¡ç³èªå·±æž¬å®ïŒSMBGïŒSelf-Monitoring of Blood GlucoseïŒ
ãã©ãã°ã¹ãã¢ã§è³Œå ¥å¯èœ. CGMãããã©ã³ãã³ã°ã³ã¹ãã¯äœã. 1æ¥150åçšåºŠ.
ðæç¶è¡ç³æž¬å®åš(CGM)
æç¶ã°ã«ã³ãŒã¹ã¢ãã¿ãªã³ã°. èšæž¬åš. 欲ãã.
è ãªã©ã«è²Œãå°åã»ã³ãµãŒã§ç®äžã®ã°ã«ã³ãŒã¹ïŒãããŠç³ïŒå€ãé£ç¶çã«æž¬å®ãããªãŒããŒïŒã¹ãããªã©ïŒããããïŒã¹ãã£ã³ããïŒã ãã§è¡ç³å€ã®å€åãã°ã©ãã§ææ¡ã§ãã.
FreeStyle Libre2
ãªãã¬.
DexcomG7
- ã»ã³ãµãŒæç¶æé:10æ¥é
- 枬å®é »åºŠ:5åããšã«èªåéä¿¡
<2026-02-12 Thu 18:27>amazonã§æ³šæãã.
https://jp.provider.dexcom.com/product/dexcom-g7-cgm
FGM
ã»ã³ãµãŒããããã¿ã€ã. CGMã§ä»£æ¿ããã€ã€ãã.
è¡ç³å€åæ
- SD: æšæºåå·®. å°ããã»ã©å®å®ããŠãã
å€åä¿æ°(cv)
CV: (Coefficient of VariationïŒ. è¡ç³å€ã®ã°ãã€ããç€ºãææš
- èšç®åŒ: CV (%) = (æšæºåå·® ÷ å¹³å) à 100
- ç®æš: 36%以äž
- æå³: CVãé«ãïŒè¡ç³å€ã®å€åã倧ããïŒäžå®å®ïŒ
EGV
Estimated Glucose Value: 5åããšã®è¡ç³å€æž¬å®å€ (mg/dL).
ðç©ºè ¹æè¡ç³å€
- 60ä»¥äž å±éºãªäœè¡ç³
- 70ã84 ããäœãïŒå¥åº·ãªäººã§ã¯çšïŒ
- 85ã95 çæ³ç
- 96ã99 æ£åžžç¯å²ã»è¯å¥œ
- 100ã109 æ£åžžé«å€ã»èŠæ³šæ
- 110ã125 å¢çåïŒããªãã®çŸåšå°ïŒ
- 126ä»¥äž ç³å°¿ç åºæº
80ããããçæ³å€. 110ããäºåè».
HbA1c
éå»1, 2ã¶æã®å¹³åå€.
GMIïŒGlucose Management IndicatorïŒ
- CGMããŒã¿ããæšå®ãããHbA1c
- èšç®åŒ: GMI (%) = 3.31 + (0.02392 à 平åè¡ç³å€)
TIRåæ
Time In Range. ç®æšç¯å²å ã®æéå²å
- æšæºç®æšç¯å²: 70-180 mg/dL
- ç®æš: 70%以äžïŒ1æ¥çŽ17æéïŒ
AGPã°ã©ã
Ambulatory Glucose Profile (AGP). International Diabetes Center (IDC) å ¬èªã®æšæºã°ã«ã³ãŒã¹å€ã¬ããŒã.
è€æ°æ¥ã®è¡ç³å€ã24æé軞ã«éãåãããçµ±èšã°ã©ã. 1æ¥1æ¥ã®æç³»åã°ã©ãã ãšã仿¥ã®è¡ç³ãã¿ãŒã³ãããããããªããã§ããæ¯æ¥12æé ã«è¡ç³ãäžããåŸåããããïŒããæ©æã¯åžžã«é«ããïŒããšããç¿æ £çãªãã¿ãŒã³ãèŠãã«ã¯ãè€æ°æ¥ãåãæé軞ã«éããå¿ èŠ.
è¡ç³ã³ã³ãããŒã«
è¡ç³å€ããããªãæ¹æ³.
é£å
30åå
- æ°Žã飲ã
- é
¢é
ž: é£äºã®15ã20ååããŸãã¯é£äºäžã«å€§ãã1æ¯
- ãªã³ãŽé ¢, ã¬ã¢ã³æ°Ž
ã«ãŒãã©ã¹ã
é£äºã®ã·ãŒã¯ãšã³ã·ã³ã°ïŒFood SequencingïŒ, ãã¬ããŒãã£ã³ã°ïŒPreloadingïŒ. ã«ãŒãã©ã¹ã.
- é£ç©ç¹ç¶
- è質/ããã±ã質
- çæ°Žåç©
é£åã®ã¢ãŒã¢ã³ã
å€é£ãªããããæé£ãªããã®ã»ããã¹ãã€ã¯ãå°ãªã
é£äºã®éå¿ãæãæŒã«ã·ãã
é£åŸ
é£åŸ10åã®ãŠã©ãŒãã³ã°
10åã§ã30åã§ãç ç©¶çã«ã¯åã.
éå
ãšãã«ããŒã¯ãŸã§ã®1æé以å . äžæäžã¯æé žçŽ éåã§ãããŠç³ãæžãã.
éé£ãããã
ã¹ãã€ã¯ãé²ãæŠç¥. ãã«ããã²ãšããããªã©. ããããé£ã¹ã.
ç©ºè ¹æè¡ç³å€ãäžããæ¹æ³
ðã€ã³ã¹ãªã³æµææ§ãé«ããæ¹æ³. è¡ç³å€ã¹ãã€ã¯ãé²ããäžçªãã.
è¡ç³å€ã¹ãã€ã¯ãé²ã
ã¹ãã€ã¯ãç¹°ãè¿ããã³ã«ã€ã³ã¹ãªã³ã®å¹ããæªããªãããããæ ¢æ§çãªé«è¡ç³ã®äž»å ã«ãªã£ãŠãã. éã«èšãã°ã¹ãã€ã¯ãé²ãããšãã€ã³ã¹ãªã³æåæ§ã®å埩ã«ã€ãªãã.
- ã«ãŒãã©ã¹ã
- é£åŸã®ãŠã©ãŒãã³ã°
ã¿ã³ã¯ç©ºã£ãœç³»
- ç»å±±
- æ°Žæ³³
- ðŽãã³ã°ã©ã€ã: ã€ã³ã¹ãªã³æåæ§ãé«ãŸã£ãŠãã72æé. ã©ã€ãåŸç¿æ¥ããã«ãã«ãã.
ã¿ã³ã¯å®¹éå¢å€§
- ðªçãã¬: çã°ãªã³ãŒã²ã³ãžã®åã蟌ã¿å®¹éãå¢ãã.
æåæ§ç³»
- âšãµãŠã: ç±ã¹ãã¬ã¹ãšå·æ°Žã¹ãã¬ã¹ã«ãã£ãŠã€ã³ã¹ãªã³æåæ§ãæ¹å
- å·æ°Žã·ã£ã¯ãŒ
- ç¡ç ã®è³ª
- ðããæé£
ðç³å°¿ç
ã€ã³ã¹ãªã³ã®åæ³äžè¶³ãäœçšäœäžã«ããæ ¢æ§çã«é«è¡ç³ãç¶ãçŸæ£. é«è¡ç³.
- 2åç³å°¿ç (å šäœã®90%以äž): ã€ã³ã¹ãªã³ãåºã«ããããŸãã¯å¹ãã«ããïŒã€ã³ã¹ãªã³æµææ§ïŒç¶æ ãçæŽ»ç¿æ £ãè¥æºãéºäŒãå 霢ãäž»ãªèŠå ã
- 1åç³å°¿ç : èµèã®çްèãç Žå£ãããã€ã³ã¹ãªã³ãã»ãŒåæ³ãããªããªããèªå·±å ç«ãªã©ãé¢ä¿ã
çç¶
- åŠæ æ, æ ¢æ§çãªç²åŽæ. æèµ·ããã®ãèŸããæ¥åžžçãªã¿ã¹ã¯ãããªãã®ãã€ãããšæãã
- ã€ã©ã€ã©ã»æ°åã®å€åè¡ç³å€ã®å€åã«ãããã€ã©ã€ã©ãæ°åã®å€åãèµ·ãã
- åã®æžã
- é »å°¿
å¢çåç³å°¿ç
ðCGMãã€ããŠç³å°¿ç äºåè»ã§ããããšãçºèŠãã(26/02/17)
ðäœè¡ç³
Topics
è¡ç³å€ã®ä¹±ãã¯èªåŸç¥çµã®ä¹±ã
èªåŸç¥çµã¯è¡ç³å€ã«ãããã«åœ±é¿ãåãã.
è¡ç³å€ããããªãéé£
- ãã§åµ, dexcom g7ã§èšæž¬ãã. ã»ãŒäžãããªã.
- ããŒãº
- ç¡ç³ãšãŒã°ã«ã
- ãããé¡
- ãããã»ããããïŒç¡æ·»å ïŒ
- ãã€ã«ã«ãªããŒã¯ãã§ã³ã¬ãŒã
Insights
ðå¿ã®ä¹±ãã¯è¡ç³å€ã®ä¹±ã
ããããçæ³ãšãå¿çåŠãåŠã¶ããããé£äºãç°¡åãªã®ã§ã¯ãªããïŒ